Revenue -Schedule of Accounts Receivable, Unbilled Services, and Deferred Revenue (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Deferred revenue | |||
| Deferred revenue, beginning balance | $ 498,996 | $ 1,121,886 | |
| Additions | 13,550 | 0 | |
| Deductions | (64,501) | (603,995) | |
| Deferred revenue, ending balance | 448,045 | $ 517,891 | |
| Revenue Recognition | |||
| Deferred revenue | 88,772 | $ 140,053 | |
| Sanofi Transition Services | |||
| Revenue Recognition | |||
| Deferred revenue | 44,500 | ||
| Other partners | |||
| Revenue Recognition | |||
| Deferred revenue | 10,300 | ||
| Nuvaxovid | |||
| Revenue Recognition | |||
| Deferred revenue | 9,600 | ||
| Canada Advanced Purchase Agreement | |||
| Revenue Recognition | |||
| Deferred revenue | $ 555,700 | ||
| X | ||||||||||
- Definition Contract With Customer, Liability, Additions No definition available.
|
| X | ||||||||||
- Definition Contract With Customer, Liability, Deductions No definition available.
|
| X | ||||||||||
- Definition Deferred Revenue Increase (Decrease) No definition available.
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|